FDA to review BLA for CLN2 treatment
First potential treatment for CLN2 on fast track for development. Read More »
Boots franchise to open in South Korea
Franchise partnership agreement signed with Emart last week. Read More »
Cancer vaccine collaboration announced
Cancer vaccine WO-12 to be developed by Pfizer and Western Oncolytics. Read More »
FDA approves lixisenatide for Type 2 diabetes treatment
Approved for use with diet and exercise; also approved as a combination therapy with other diabetes medications and insulin. Read More »
Cancer drug delivery fast shifting, more changes likely
Jostling among hospitals, pharmacies, doctors, and third-party payers over the delivery of specialty cancer drugs is likely to intensify, according to experts observing the already fast shifting field of oncology treatment channeling. Read More »
Galmed and SAMIL announce license agreement for Aramchol
Galmed Pharmaceuticals Ltd. and SAMIL Pharm. Co.recently announced that a license agreement has been put into place for an exclusive, royalty-bearing license for Aramchol and its commercialization. Read More »
Cytokinetics and Astellas announce expanded collaboration
Cytokinetics, Inc. and Astellas Pharma, Inc. have announced the expansion of their collaboration in skeletal muscle activators for the inclusion of amyotrophic lateral sclerosis (ALS). Read More »
Financial professional Kavanagh joins Valeant board of directors
Board increases to 12 members; 11 are independent directors. Read More »
GNE myopathy Phase III clinical trial completes patient enrollment
Rare disease leads to severe disability; no approved therapy yet. Read More »
FDA approves Silvergate’s Qbrelis
The U.S. Food and Drug Administration (FDA) has approved Silvergate Pharmaceuticals’ Qbrelis Oral Solution, the first Lisinopril oral solution that has been approved by the agency. Read More »
Pfizer published Phase 3 crisaborole data
Pfizer Inc. recently published the findings from two pivotal Phase III studies of crisaborole topical ointment 2 percent, formerly known as AN2728. Read More »
Discount coupon reduces cost of life-saving NARCAN
Partnership makes NARCAN Nasal Spray more affordable at CVS Pharmacies. Read More »
DEA asks NACDS to share Pharmacy Diversion Awareness Conference information
The Drug Enforcement Administration’s (DEA) Liaison and Policy Section has asked that the National Association of Chain Drug Stores (NACDS) to share information regarding its Pharmacy Diversion Awareness Conferences that will be held in August with member companies. Read More »
Pfizer announces positive OCTAVE Sustain results
Pfizer Inc. recently announced that its third Phase III study of XELJANZ (tofacitinib citrate), Oral Clinical Trials for tofacitinib in ulcerative colitis (OCTAVE) Sustain, has turned in positive result Read More »
Galmed names Dr. Ran Oren Chief Medical Officer
Galmed Pharmaceuticals has announced that Professor Ran Oren, M.D., has been named its Chief Medical Officer (CMO). Read More »
USPTO issues Notice of Allowance for Ardelyx’s RDX227675
Ardelyx Inc. recently announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its composition of matter patent application for RDX227675. Read More »
Medicare premium to stay stable
With only the slightest of increases, Medicare recently announced that the average monthly cost for a Medicare Part D prescription drug plan in 2017 is projected to remain reasonably stable at approximately $34. Read More »
PTO grants Argentum IPR petition against PAZEO
Argentum Pharmaceuticals recently announced that it, along with its manufacturing partner KVK Tech, has been granted a petition for inter partes review (IPR) against all challenged claims of the sole patent that covers Alcon’s PAZEO by the U.S. Patent & Trademark Office (PTO). Read More »
HedgePath announces positive interim results on Phase IIb cancer trial
Basal cell carcinoma nevus syndrome patients show positive results after 16 weeks in the study. Read More »
Evelo and Mayo Clinic to collaborate on cancer therapies
Collaboration to contribute to Evelo's cancer-associated bacteria library. Read More »
Alerts Sign-up